Release 4B Snapshot #1

This page is part of the FHIR Specification (v4.3.0-snapshot1: Release 4B Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Evidencevariable-example-alteplase-for-stroke.json

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

Raw JSON (canonical form + also see JSON Format Specification)

Alteplase for Stroke

{
  "resourceType": "EvidenceVariable",
  "id": "example-alteplase-for-stroke",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <p>\n        &quot;Alteplase for Stroke&quot; is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n      </p>\n\t</div>"
  },
  "title": "Alteplase for Stroke",
  "status": "draft",
  "useContext": [
    {
      "code": {
        "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
        "code": "focus"
      },
      "valueCodeableConcept": {
        "text": "Stroke"
      }
    }
  ],
  "actual": true,
  "characteristic": [
    {
      "description": "IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour",
      "definitionCanonical": "http://example.org/fhir/ActivityDefinition/example-alteplase-dosing"
    }
  ]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.